Bailard’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.5M | Buy |
49,711
+146
| +0.3% | +$52K | 0.4% | 56 |
|
|
2025
Q4 | $16.2M | Buy |
49,565
+1,356
| +3% | +$430K | 0.36% | 62 |
|
|
2025
Q3 | $13.6M | Sell |
48,209
-1,249
| -3% | -$362K | 0.3% | 69 |
|
|
2025
Q2 | $13.8M | Buy |
49,458
+2,925
| +6% | +$829K | 0.32% | 69 |
|
|
2025
Q1 | $14.5M | Buy |
46,533
+1,008
| +2% | +$298K | 0.37% | 63 |
|
|
2024
Q4 | $11.9M | Sell |
45,525
-1,200
| -3% | -$356K | 0.3% | 79 |
|
|
2024
Q3 | $15.1M | Sell |
46,725
-138
| -0.3% | -$45.1K | 0.39% | 59 |
|
|
2024
Q2 | $14.6M | Buy |
46,863
+205
| +0.4% | +$60.2K | 0.4% | 54 |
|
|
2024
Q1 | $13.3M | Sell |
46,658
-198
| -0.4% | -$57.9K | 0.37% | 61 |
|
|
2023
Q4 | $13.5M | Buy |
46,856
+1,243
| +3% | +$339K | 0.4% | 52 |
|
|
2023
Q3 | $12.3M | Buy |
45,613
+5,841
| +15% | +$1.46M | 0.41% | 54 |
|
|
2023
Q2 | $8.83M | Buy |
39,772
+609
| +2% | +$141K | 0.31% | 75 |
|
|
2023
Q1 | $9.47M | Buy |
39,163
+959
| +3% | +$235K | 0.34% | 72 |
|
|
2022
Q4 | $10M | Sell |
38,204
-448
| -1% | -$120K | 0.38% | 60 |
|
|
2022
Q3 | $8.71M | Buy |
38,652
+6,770
| +21% | +$1.64M | 0.36% | 62 |
|
|
2022
Q2 | $7.76M | Buy |
31,882
+16,971
| +114% | +$4.16M | 0.31% | 75 |
|
|
2022
Q1 | $3.61M | Buy |
14,911
+1,057
| +8% | +$243K | 0.12% | 149 |
|
|
2021
Q4 | $3.12M | Buy |
13,854
+453
| +3% | +$95.6K | 0.1% | 155 |
|
|
2021
Q3 | $2.85M | Sell |
13,401
-357
| -3% | -$82.2K | 0.1% | 163 |
|
|
2021
Q2 | $3.35M | Buy |
13,758
+569
| +4% | +$140K | 0.12% | 154 |
|
|
2021
Q1 | $3.28M | Sell |
13,189
-1,100
| -8% | -$262K | 0.12% | 151 |
|
|
2020
Q4 | $3.29M | Buy |
14,289
+257
| +2% | +$59.3K | 0.15% | 121 |
|
|
2020
Q3 | $3.57M | Buy |
14,032
+488
| +4% | +$121K | 0.18% | 103 |
|
|
2020
Q2 | $3.19M | Buy |
13,544
+3,884
| +40% | +$886K | 0.18% | 112 |
|
|
2020
Q1 | $1.96M | Buy |
9,660
+256
| +3% | +$55.9K | 0.14% | 130 |
|
|
2019
Q4 | $2.27M | Sell |
9,404
-252
| -3% | -$55.5K | 0.13% | 146 |
|
|
2019
Q3 | $1.87M | Buy |
9,656
+747
| +8% | +$143K | 0.11% | 161 |
|
|
2019
Q2 | $1.64M | Sell |
8,909
-43
| -0.5% | -$7.7K | 0.1% | 175 |
|
|
2019
Q1 | $1.7M | Sell |
8,952
-1,481
| -14% | -$283K | 0.11% | 174 |
|
|
2018
Q4 | $2.03M | Buy |
10,433
+3,736
| +56% | +$729K | 0.14% | 143 |
|
|
2018
Q3 | $1.39M | Buy |
6,697
+2,114
| +46% | +$417K | 0.08% | 190 |
|
|
2018
Q2 | $846K | Sell |
4,583
-432
| -9% | -$76.4K | 0.05% | 241 |
|
|
2018
Q1 | $855K | Buy |
5,015
+350
| +8% | +$64.2K | 0.05% | 233 |
|
|
2017
Q4 | $811K | Buy |
4,665
+73
| +2% | +$12.9K | 0.05% | 254 |
|
|
2017
Q3 | $856K | Hold |
4,592
| – | – | 0.07% | 178 |
|
|
2017
Q2 | $791K | Sell |
4,592
-295
| -6% | -$48K | 0.06% | 184 |
|
|
2017
Q1 | $802K | Buy |
4,887
+95
| +2% | +$15.8K | 0.07% | 188 |
|
|
2016
Q4 | $701K | Sell |
4,792
-3,487
| -42% | -$525K | 0.06% | 179 |
|
|
2016
Q3 | $1.38M | Buy |
8,279
+970
| +13% | +$164K | 0.13% | 144 |
|
|
2016
Q2 | $1.11M | Buy |
7,309
+465
| +7% | +$72.3K | 0.13% | 149 |
|
|
2016
Q1 | $1.03M | Buy |
6,844
+1,844
| +37% | +$274K | 0.14% | 104 |
|
|
2015
Q4 | $812K | Sell |
5,000
-649
| -11% | -$102K | 0.36% | 102 |
|
|
2015
Q3 | $781K | Buy |
5,649
+1,000
| +22% | +$158K | 0.12% | 108 |
|
|
2015
Q2 | $714K | Sell |
4,649
-325
| -7% | -$52.1K | 0.11% | 114 |
|
|
2015
Q1 | $795K | Hold |
4,974
| – | – | 0.11% | 117 |
|
|
2014
Q4 | $792K | Buy |
4,974
+11
| +0.2% | +$1.71K | 0.11% | 116 |
|
|
2014
Q3 | $697K | Buy |
4,963
+1,840
| +59% | +$240K | 0.11% | 106 |
|
|
2014
Q2 | $370K | Sell |
3,123
-865
| -22% | -$100K | 0.06% | 153 |
|
|
2014
Q1 | $492K | Sell |
3,988
-458
| -10% | -$55.5K | 0.08% | 134 |
|
|
2013
Q4 | $507K | Sell |
4,446
-549
| -11% | -$62.5K | 0.08% | 136 |
|
|
2013
Q3 | $559K | Sell |
4,995
-10,888
| -69% | -$1.18M | 0.11% | 148 |
|
|
2013
Q2 | $1.57M | Buy |
+15,883
| New | +$1.65M | 0.29% | 74 |
|
Other funds holding AMGN
VCM
VPM
Bailard's AMGN Position: Q1 2026 in Review
Bailard increased its Amgen (AMGN) stake by 0.29% in Q1 2026, buying an estimated $52K and bringing the position to 49,711 shares worth $17.5M. The position accounts for 0.4% of the portfolio, ranked #56.
Bailard first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Bailard held 49,711 shares of Amgen worth $17.5M as of Q1 2026.
- Bailard bought 146 Amgen shares in Q1 2026, an estimated $52K.
- Amgen made up 0.4% of Bailard's portfolio in Q1 2026, its #56 holding.
- Bailard first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.